6Norris HJ, Bahr GF,Mikel UV, A comparative morphometryc and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast, Anal Quant Cytol Histol,1988,10:l.
7Spyratos F ,Briffod M, Gentile A, et al : Flow cytometric styoly of DNA distribution in cytopunctures of benign and malignant breast lesions. Anal Quant Cytol Histol, 1987, 9: 485.
8Baak JPA:Manual of quantitative pathology in cancer diagnosis and prognosis. Berlin Heidelberg New York: Springer-Verlag.1991:218
9Bichel P, Poulsen HS, Andersen J. Estrogen receptor content and ploidy of human mammary carcinoma . Cancer, 1982,50:1771.
10Bacus SS, Ruby SG, Weinberg DS, et al. HER 2/awe oncogene expression and proliferation in breast cancers. Am J pathol,1990 ,137 :10 3.
5Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer [J]. Br JCancer, 1957, 11:359- 364.
6Gundersen HJG., The nucleator. J. Microsc, 1988, 151:5-6.
7Gundersen HJG., Bagger P, Bendtse FT. The new sterological tools: Disector fractionator and point sampled intercept and their use in pathological research and diagnosis [J].APMIS, 1988, 96:857 - 860.
8G. Haroske, F Giroud, A Reith, et al. 1997 ESCAP consensus report on diagnostic DNA image cytometery Part; Bisic consideration and recommendations preparation measurement and interpretation. Analytical Cellular Pathology, 1998,17:189 - 200.
9M Rudas, R Neumayer, M MitteIbock, et al. P53 Protein Ex pression, Cell Proliferation and Steroid Hormone Receptors in Ductal and Lobular In Situ Carcinomas of the Breast[J]. European Journal of Cancer Part A. January, 1997, 33(1): 39 - 44.
10Kinne DN. ER protein in breast cancer as a predictor of recurrence [J]. Cancer, 1981,47 (10): 2764- 2766.
